Our latest news
- NTRK gene fusions, TRK inhibitors and testing approaches BluePrint NTRK CONNECT identified NTRK Gene Fusions on the ESMO OncologyPro portal as a practical guide on how to test for NTRK gene fusions and treat with TRK inhibitors.
- Review of the BEACON Study Prof. Armin Gerger provides a review of the BEACON Study.
- SARCOMA CONNECT Update from CTOS 2019 SARCOMA CONNECT has summarised highlights of the recent CTOS 2019 meeting for you, by Dr Rick Haas.
- Insights into trial designs in advanced HCC Dr. Leonardo da Fonseca provides insights into trial designs in advanced hepatocellular carcinoma (HCC).
- Good Diagnostic Practices for Sarcoma and Early Referral to Specialised Centres Prof. Piotr Rutkowski provides his thoughts on Good Diagnostic Practices for Sarcoma
- Treatment sequencing in advanced HCC Prof. Peter Galle, Dr. Ruth He, Dr. Kirti Shetty and Dr. David Kleiner discussed the topic 'Treatment sequencing in advanced HCC' at an Experts Knowledge Share held during AASLD 2019. Please click the link to download the slides.
- HCC CONNECT Update from AASLD 2019 HCC CONNECT has summarised the highlights from ASCO 2019 for you
- Practice changing clinical trials in NET Dr. Joakim Crona provides an overview of practice changing clinical trials within the field of neuroendocrine tumours and neuroendocrine carcinomas
- ASH 2019 registration
- GI CONNECT Experts Knowledge Share ESMO 2019: TRIBE-2, Re-ARRANGE and FOxTROT CRC data Dr. Fotios Loupakis led a very interesting meeting addressing the question 'How will TRIBE-2, Re-ARRANGE and FOxTROT in colorectal cancer (CRC) impact your current sequential clinical practice?' during a recent GI CONNECT Experts Knowledge Share. Dr. Guillem Argilés discussed data from Re-ARRANGE, Dr. Chiara Cremolini discussed data from TRIBE-2 and Dr. Jenny Seligmann discussed data from FOxTROT.